Chemotherapy in the community: what do patients want?
The aim of this study was to compare the outcomes of chemotherapy delivered at a cancer centre with chemotherapy given at a community hospital. The services were compared in terms of safety, preference for location, satisfaction and resource use. Patients were randomly allocated to two groups. One group received their first two cycles of chemotherapy at a community hospital; the other group received theirs at the cancer centre. The patients then crossed over to receive their next two cycles of chemotherapy at outreach or the cancer centre and then chose where they wanted to receive the remaining two cycles of their chemotherapy. Data were collected about patient preference, anxiety and depression, satisfaction and chemotherapy-related toxicity. Forty-two patients were randomized to the study: 38, 31 and 28 patients completed cycles two, four and final chemotherapies respectively. Thirty-one patients reached the end of the crossover period, of which 30 chose the outreach location for the remainder of their chemotherapy treatments. There was strong evidence that patients were more satisfied with outreach location for ease of access and also the environment. Recommendation from this study was that a permanent outreach chemotherapy service to community hospitals be established.
Pace
E
E
Department of Blood and Cancer Services, Derriford Hospital, Plymouth, UK.
Dennison
S
S
Morris
J
J
Barton
A
A
Pritchard
C
C
Rule
S A J
SA
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D002173:Cancer Care Facilities; D018592:Cross-Over Studies; D003695:Delivery of Health Care; D005260:Female; D006297:Health Services Accessibility / Q000191:economics; D006764:Hospitals, Community; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics; D017060:Patient Satisfaction; D016896:Treatment Outcome
D000970:Antineoplastic Agents